Awakn Via Amitis, a jointly owned by Via (formerly WDP) a UK healthcare charity providing addiction and mental health services in the UK, and Amitis Group, a private UK investment company, completed the acquisition of Awakn London, a clinical-stage biotechnology company developing therapeutics targeting addiction. Financial terms were not disclosed. "We are very pleased to have completed this transaction, which is an important milestone for Awakn and one which will allow us to focus our resources on our R&D programs. Critically, it also will allow continutiy of care for our clients and workforce in London. We also believe that the consortium is excellently positioned with their experience and close working partnership with the NHS to grow and scale the clinics business, hopefully allowing access to a whole new cohort of patients in desperate need of a new and more effective treatment option. We look forward to working with them as partners and sharing in their future success," Anthony Tennyson, Awakn CEO.